Ergocalciferol Oral Capsule, Liquid Filled 1.25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ergocalciferol: Oral capsule, liquid filled (1.25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_9243.JPG
Ergocalciferol 1.25mg Cap
Pliva Inc a Division of Teva USA
Pill Identification: D140,PA140 
Drug Image file DrugItem_9243.JPG
Ergocalciferol 1.25mg Cap
Pliva Inc a Division of Teva USA
Pill Identification: D140,PA140 
Drug Image file DrugItem_16035.JPG
Ergocalciferol 1.25mg Cap
Winthrop U.S., a business of Sanofi-Aventis
Pill Identification: E 50 
Drug Image file DrugItem_18435.JPG
Vitamin D 1.25mg Cap
American Health Packaging
Pill Identification: A3 
Drug Image file DrugItem_18434.JPG
Vitamin D 1.25mg Cap
Breckenridge Inc
Pill Identification: A3 

What is this Medicine?

ERGOCALCIFEROL (er goe kal SIF e role) is a man made form of vitamin D. It helps your body keep the right amount of calcium and phosphorus for healthy bones and teeth.

CVS Pharmacy Patient Statistics for Ergocalciferol: Oral capsule, liquid filled(1.25mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Ergocalciferol 1.25mg Capsule

NDC: 501110990
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Rickets, Hypoparathyroidism, Nutritional Supplementation, Vitamin D Deficiency, Familial Hypocholesterolemia, Hereditary Vitamin D Resistant Rickets

Sometimes used for but not FDA approved for the following conditions:
Osteoporosis, Premenstrual Syndrome (PMS), Renal Osteodystrophy

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from light
Ergocalciferol 1.25mg Capsule
Drug Image file DrugItem_9242.JPG
Pliva Inc a Division of Teva USA
Pill Identification: D140,PA140 
Shape: capsule
Color: green
Drug Image file DrugItem_9243.JPG
Pliva Inc a Division of Teva USA
Pill Identification: D140,PA140 
Shape: capsule
Color: green

Reported Side Effects for Ergocalciferol 1.25mg Capsule

Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
High Calcium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Urine Calcium Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Vitamin D Levels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Increased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Irritability Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Excessive Thirst Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ergocalciferol

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.